Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $276,819 | 58 | 91.4% |
| Consulting Fee | $18,291 | 1 | 6.0% |
| Food and Beverage | $5,462 | 126 | 1.8% |
| Travel and Lodging | $2,218 | 4 | 0.7% |
| Gift | $45.00 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Glaukos Corporation | $297,878 | 83 | $0 (2024) |
| LENSAR, Inc. | $772.35 | 2 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $688.41 | 21 | $0 (2021) |
| Alcon Vision LLC | $679.94 | 16 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $600.10 | 7 | $0 (2023) |
| Allergan, Inc. | $521.10 | 15 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $486.60 | 7 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $251.51 | 8 | $0 (2021) |
| ABBVIE INC. | $207.68 | 7 | $0 (2024) |
| Carl Zeiss Meditec USA, Inc. | $154.68 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,043 | 13 | Glaukos Corporation ($21,770) |
| 2023 | $825.11 | 16 | Glaukos Corporation ($201.60) |
| 2022 | $32,705 | 34 | GLAUKOS CORPORATION ($31,127) |
| 2021 | $79,446 | 34 | Glaukos Corporation ($78,894) |
| 2020 | $75,796 | 24 | Glaukos Corporation ($75,483) |
| 2019 | $89,016 | 31 | Glaukos Corporation ($88,538) |
| 2018 | $919.94 | 16 | Glaukos Corporation ($377.89) |
| 2017 | $2,083 | 22 | Glaukos Corporation ($1,485) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Glaukos Corporation | iDose (Device) | Consulting Fee | Cash or cash equivalent | $18,290.86 | General |
| Category: Glaucoma | ||||||
| 09/30/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: EYE CARE | ||||||
| 08/27/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Ophthalmology | ||||||
| 08/01/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $45.51 | General |
| Category: Glaucoma | ||||||
| 07/08/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $64.97 | General |
| Category: Ophthalmology | ||||||
| 05/30/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: EYE CARE | ||||||
| 04/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $32.24 | General |
| Category: Ophthalmology | ||||||
| 04/10/2024 | Glaukos Corporation | iStent inject Trabecular Micro-Bypass System (Device) | Food and Beverage | Cash or cash equivalent | $171.47 | General |
| Category: Glaucoma | ||||||
| 04/10/2024 | Glaukos Corporation | iStent inject Trabecular Micro-Bypass System (Device) | Travel and Lodging | Cash or cash equivalent | $92.01 | General |
| Category: Glaucoma | ||||||
| 04/03/2024 | Glaukos Corporation | G2-TR_iDoseTR (Device) | — | Cash or cash equivalent | $1,935.00 | Research |
| Study: Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% • Category: Glaucoma | ||||||
| 03/06/2024 | Glaukos Corporation | GS-M-IS_iStent inject Trabecular Micro-Bypass System Model G2-M-IS (Device) | — | Cash or cash equivalent | $1,135.00 | Research |
| Study: iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study • Category: Glaucoma | ||||||
| 03/06/2024 | Glaukos Corporation | G2-TR_iDoseTR (Device) | — | Cash or cash equivalent | $100.00 | Research |
| Study: Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% • Category: Glaucoma | ||||||
| 02/28/2024 | Bausch & Lomb Americas Inc. | STELLARIS (Device) | Food and Beverage | In-kind items and services | $127.61 | General |
| Category: Ophthalmology | ||||||
| 12/22/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $42.15 | General |
| Category: Ophthalmology | ||||||
| 12/12/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: EYE CARE | ||||||
| 11/20/2023 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Ophthalmology | ||||||
| 11/07/2023 | Bausch & Lomb Americas Inc. | STELLARIS (Device) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Ophthalmology | ||||||
| 10/05/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $123.20 | General |
| Category: EYE CARE | ||||||
| 09/25/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $17.56 | General |
| 09/19/2023 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Simplicity (Device), CATALYS SYSTEM | Food and Beverage | In-kind items and services | $93.37 | General |
| Category: Optics | ||||||
| 07/21/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: EYE CARE | ||||||
| 07/13/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: Ophthalmology | ||||||
| 05/17/2023 | Glaukos Corporation | iDose TR (Drug) | Food and Beverage | Cash or cash equivalent | $160.47 | General |
| Category: Glaucoma | ||||||
| 05/11/2023 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $104.95 | General |
| Category: Ophthalmology | ||||||
| 05/06/2023 | Carl Zeiss Meditec USA, Inc. | IOLMaster 700 (Device) | Food and Beverage | In-kind items and services | $154.68 | General |
| Category: Optical Biometer | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5 | Glaukos Corporation | $167,315 | 27 |
| Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% | Glaukos Corporation | $77,518 | 13 |
| iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | Glaukos Corporation | $1,135 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,871 | 2,325 | $1.2M | $280,177 |
| 2022 | 16 | 2,020 | 2,543 | $1.2M | $298,359 |
| 2021 | 15 | 2,071 | 2,717 | $1.4M | $350,652 |
| 2020 | 16 | 2,158 | 2,672 | $1.4M | $327,046 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 192 | 332 | $664,000 | $122,667 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 319 | 561 | $84,150 | $34,937 | 41.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 201 | 201 | $67,134 | $22,504 | 33.5% |
| 66183 | Insertion of eye fluid drainage device | Facility | 2023 | 14 | 20 | $42,660 | $16,659 | 39.1% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 53 | 53 | $47,900 | $15,211 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 165 | $27,390 | $14,970 | 54.7% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 18 | 26 | $78,000 | $13,782 | 17.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 108 | 109 | $23,653 | $9,567 | 40.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 178 | 190 | $28,250 | $8,783 | 31.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 202 | 203 | $42,224 | $7,010 | 16.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 166 | 188 | $15,604 | $4,624 | 29.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 44 | 44 | $13,200 | $4,361 | 33.0% |
| 92250 | Photography of the retina | Office | 2023 | 68 | 68 | $8,500 | $1,832 | 21.5% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 75 | 78 | $3,900 | $1,644 | 42.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 17 | $1,428 | $700.50 | 49.1% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 55 | 55 | $1,485 | $469.68 | 31.6% |
| 92134 | Imaging of retina | Office | 2023 | 15 | 15 | $1,245 | $456.59 | 36.7% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 206 | 363 | $728,500 | $135,190 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 313 | 553 | $82,950 | $34,892 | 42.1% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 101 | 102 | $96,900 | $30,607 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 243 | 243 | $81,162 | $25,327 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 228 | 262 | $43,492 | $22,476 | 51.7% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 17 | 26 | $73,667 | $13,085 | 17.8% |
| 92133 | Imaging of optic nerve | Office | 2022 | 238 | 305 | $25,315 | $7,928 | 31.3% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 220 | 221 | $45,968 | $7,683 | 16.7% |
About Dr. James Burden, MD
Dr. James Burden, MD is a Ophthalmology healthcare provider based in Colorado Springs, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538180146.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Burden, MD has received a total of $302,835 in payments from pharmaceutical and medical device companies, with $22,043 received in 2024. These payments were reported across 190 transactions from 20 companies. The most common payment nature is "" ($276,819).
As a Medicare-enrolled provider, Burden has provided services to 8,120 Medicare beneficiaries, totaling 10,257 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Colorado Springs, CO
- Active Since 07/21/2006
- Last Updated 04/07/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1538180146
Products in Payments
- iDose (Device) $18,336
- G2-TR_iDoseTR (Device) $2,035
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $1,455
- GS-M-IS_iStent inject Trabecular Micro-Bypass System Model G2-M-IS (Device) $1,135
- STELLARIS (Device) $801.59
- LENSAR LASER SYSTEM (Device) $772.35
- iSTENT iNJECT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $368.90
- DURYSTA (Drug) $308.03
- iStent inject Trabecular Micro-Bypass System (Device) $263.48
- HYDRUS Microstent (Device) $250.67
- Tecnis 1-piece IOL (Device) $227.67
- Tecnis Simplicity (Device) $207.98
- LUMIGAN (Drug) $197.46
- LOTEMAX GEL (Drug) $176.27
- Clareon (Device) $172.51
- Ophthalmic Surgical Adjuncts (Device) $164.45
- ISTENT INJECT W (Device) $162.56
- iDose TR (Drug) $160.47
- LOTEMAX SM (Drug) $157.65
- IOLMaster 700 (Device) $154.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Colorado Springs
Dr. Steven Dewey, Md, MD
Ophthalmology — Payments: $275,298
James Lee, Md, MD
Ophthalmology — Payments: $31,764
Adam Martidis, Md, MD
Ophthalmology — Payments: $20,307
Erik Anderson, M.d, M.D
Ophthalmology — Payments: $7,145
Dr. Jason Noble, Md, MD
Ophthalmology — Payments: $6,724
Dr. John Roberts, M.d, M.D
Ophthalmology — Payments: $5,484